ARTICLE | Clinical News
Noven regulatory update
March 28, 1994 8:00 AM UTC
Noven Pharmaceuticals Inc. (NOVN) The Miami company's transdermal estrogen replacement system received an Approvable Letter from the FDA. The approval for the 3-1/2 day patch includes four dosing stre...